PSN:LSEPersimmon Plc Analysis
Data as of 2026-03-11 - not real-time
£1,282.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The share is trading below its short‑term and mid‑term moving averages, and momentum is in the oversold zone, suggesting a near‑term price correction could be on the cards. The broader market signal is bullish and the beta is low, pointing to limited systematic risk.
Fundamentally the company delivers solid revenue growth and respectable margins, though cash conversion is weak and the dividend payout is high, raising questions about sustainability. The discounted cash‑flow model implies a sizable valuation gap, and analyst consensus targets sit above the current level, supporting a buy case.
Volatility remains elevated and the residential construction sector is cyclical, with regulatory and planning constraints adding to the mix. Nevertheless, the company’s UK‑centric footprint limits geographic exposure and the currency environment is stable, resulting in a moderate overall risk profile.
Fundamentally the company delivers solid revenue growth and respectable margins, though cash conversion is weak and the dividend payout is high, raising questions about sustainability. The discounted cash‑flow model implies a sizable valuation gap, and analyst consensus targets sit above the current level, supporting a buy case.
Volatility remains elevated and the residential construction sector is cyclical, with regulatory and planning constraints adding to the mix. Nevertheless, the company’s UK‑centric footprint limits geographic exposure and the currency environment is stable, resulting in a moderate overall risk profile.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- oversold momentum
- price below moving averages
- low beta
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- revenue growth
- valuation upside
- analyst target support
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- housing demand fundamentals
- UK market focus
- long‑term earnings potential
Key Metrics & Analysis
Financial Health
Revenue Growth19.30%
Profit Margin7.62%
P/E Ratio16.2
ROE8.02%
ROA5.86%
Debt/Equity0.41
P/B Ratio113.6
Op. Cash Flow£29.5M
Free Cash Flow£-78537504
Technical Analysis
TrendBullish
RSI32.5
Support£1,211.50
Resistance£1,552.00
MA 20£1,444.05
MA 50£1,422.86
MA 200£1,267.27
MACDBearish
VolumeIncreasing
Fear & Greed Index78.34
Valuation
Fair Value£230.12
Target Price£1,626.11
Upside/Downside26.84%
GradeUndervalued
TypeBlend
Dividend Yield1.88%
Risk Assessment
Beta0.31
Volatility37.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.